BioCatalyst

Povorcitinib — catalyst calendar

3 verified catalyst event(s) referencing Povorcitinib, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10-19
in 29d
ESTIMATED
 READOUT
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participant
Phase 3 · Prurigo Nodularis
 INCY INCYTE CORP Povorcitinib ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-10-19
in 29d
ESTIMATED
 READOUT
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participant
Phase 3 · Prurigo Nodularis
 INCY INCYTE CORP Povorcitinib ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-26
in 3mo
ESTIMATED
 READOUT
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Partici
Phase 3 · Hidradenitis Suppurativa (HS)
 INCY INCYTE CORP Povorcitinib ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.